SCHEMBL17082397

SCHEMBL17082397

CCCCOC[C@H]1OC(O)(c2ccc(OCCCC)nc2C)[C@@H](OCCCC)C1OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16809059 1.00 — —
SCHEMBL18081771 0.89 — —
SCHEMBL17751302 0.89 — —
SCHEMBL18081854 0.84 — —
SCHEMBL16631697 0.84 — —
SCHEMBL17082395 0.81 MEN1 (0.33) —
SCHEMBL16631945 0.81 MEN1 (0.33) —
SCHEMBL16631654 0.79 — —
SCHEMBL18081987 0.78 RARA (0.33) —
SCHEMBL18081840 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170136132-A1 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. (US) 2017-05-18 — — US disclosed
EP-3053585-A1 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF Moderna Therapeutics, Inc. (US) 2016-08-10 — — EP disclosed
EP-2918275-A1 Alternative nucleic acid molecules and uses thereof Roy, Atanu (US) 2015-09-16 — — EP disclosed
Send feedback